AM-3301

N/A

Report date: 2024/01/25 09:17:23
NME

Base Information

Drug NameAM-3301
Drug Alias NameME-3301AM-3301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMediator release inhibitorsCytokines inhibitors
TargetsCytokines
Therapy Area/IndicationsRhinitis, AllergicColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMeiji Seika Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeiji Seika Pharma
Active IndicationsN/A
Inactive IndicationsRhinitis, AllergicColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A